
Neurality is a MedTech company revolutionizing hearing diagnostics with AI-powered Auditory Brainstem Response (ABR) audiometry. Their Software as a Medical Device (SaMD) automates and improves the accuracy of hearing loss screening by instantly classifying ABR test results with up to 97% accuracy, reducing diagnostic subjectivity and wait times. Neurality's technology integrates with existing EEG equipment, enabling audiologists and healthcare providers to serve more patients efficiently while improving diagnostic precision and profitability. The company targets audiologists, healthcare providers, hearing aid manufacturers, and educational institutions, aiming to democratize access to quality hearing healthcare globally. Neurality is led by a team of Ph.D. experts in engineering, AI, and medical sciences, and is actively seeking investors and partners to scale its disruptive AI-driven hearing diagnostics solutions.

Neurality is a MedTech company revolutionizing hearing diagnostics with AI-powered Auditory Brainstem Response (ABR) audiometry. Their Software as a Medical Device (SaMD) automates and improves the accuracy of hearing loss screening by instantly classifying ABR test results with up to 97% accuracy, reducing diagnostic subjectivity and wait times. Neurality's technology integrates with existing EEG equipment, enabling audiologists and healthcare providers to serve more patients efficiently while improving diagnostic precision and profitability. The company targets audiologists, healthcare providers, hearing aid manufacturers, and educational institutions, aiming to democratize access to quality hearing healthcare globally. Neurality is led by a team of Ph.D. experts in engineering, AI, and medical sciences, and is actively seeking investors and partners to scale its disruptive AI-driven hearing diagnostics solutions.